U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 31- June 6, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 31- June 6, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 06/01/2020
Location: Teleconference
Subject: Alliance for a Stronger FDA: COVID-19 Update
FDA Participant/Group: COLIN ROM; LAURA CALIGUIRI; KEAGAN LENIHAN;
Non FDA Participant/Group: Industry, media, and other invited stakeholders

Event Date: 06/02/2020
Location: Teleconference
Subject: American Hospital Association: COVID-19 Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the American Hospital Association

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 06/02/2020
Location: Virtual
Subject: Clinical Trials Transformation Initiative (CTTI)-Margolis-FasterCures: COVID-19 Master Protocol Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from industry, academia, government, and other stakeholders

Event Date: 06/04/2020
Location: Virtual
Subject: FedHealthIT Innovation Awards: Fireside Chat
FDA Participant/Group: VIDYUT DESAI;
Non FDA Participant/Group: Industry, government, and other stakeholders

Event Date: 06/04/2020
Location: Virtual
Subject: Health AI Leadership Summit 2020 - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government and media

Event Date: 06/04/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/04/2020
Location: Virtual
Subject: Leafy Green Investigation Report
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff members of the House Agriculture Committee

Event Date: 06/04/2020
Location: Virtual
Subject: COVID-19 Update and Impacts to Dietary Supplement Industry
FDA Participant/Group: MICHAEL ROGERS; STEVEN TAVE;
Non FDA Participant/Group: Several members of the Council for Responsible Nutrition Board of Directors

Event Date: 06/05/2020
Location: Virtual
Subject: Association of Food and Drug Officials World Food Safety Day Webinar
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from across the food and beverage industry, trade associations, consumer groups, and academia

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 06/01/2020
Location: Silver Spring, MD
Subject: COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Benjamin Krasna (Embassy of Israel);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 06/02/2020
Location: Virtual
Subject: Exemption of Surplus Broiler Hatchery Eggs from Refrigeration Requirements
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the National Chicken Council (NCC)

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 06/02/2020
Location: Virtual
Subject: Animal Drug Compounding
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Food and Drug Law Institute (FDLI)

Event Date: 06/05/2020
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ANTONIA MONIQUE SENNETT; CHARLI LONG; PATRICK MCDERMOTT; SIOBHAN DELANCEY; ANNE NORRIS; ASHLEY STEEL; JOSHUA HAYES; HEATHER TATE; DOROTHY MCADAMS; AMBER MCCOIG; REGINA TAN; SUSAN BRIGHT-PONTE;
Non FDA Participant/Group: Representatives of Keep Antibiotics Working (KAW)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

 

Back to Top